Article Versions Notes

Blomquist MR, Eghlimi R, Beniwal A, Grief D, Nascari DG, Inge L, Sereduk CP, Tuncali S, Roos A, Inforzato H, et al. EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International Journal of Molecular Sciences. 2024; 25(11):6279. https://doi.org/10.3390/ijms25116279

Blomquist, Mylan R., Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G. Nascari, Landon Inge, Christopher P. Sereduk, Serdar Tuncali, Alison Roos, Hannah Inforzato, and et al. 2024. "EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma" International Journal of Molecular Sciences 25, no. 11: 6279. https://doi.org/10.3390/ijms25116279

Blomquist, M. R., Eghlimi, R., Beniwal, A., Grief, D., Nascari, D. G., Inge, L., Sereduk, C. P., Tuncali, S., Roos, A., Inforzato, H., Sharma, R., Pirrotte, P., Mehta, S., Fortin Ensign, S. P., Loftus, J. C., & Tran, N. L. (2024). EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International Journal of Molecular Sciences, 25(11), 6279. https://doi.org/10.3390/ijms25116279